An Extension of the CONCERT Protocol (DIM18)

Summary

An open-label extension study of the CONCERT (DIM18) protocol evaluating the safety of dimebon (latrepirdine) in subjects with With Mild-to-Moderate Alzheimer's Disease on Donepezil.

Timeline

Start

2010-04

Primary completion

2012-05

Completion

—

Drugs

Indications